M. K. Kathiravan

2.3k total citations · 1 hit paper
98 papers, 1.7k citations indexed

About

M. K. Kathiravan is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, M. K. Kathiravan has authored 98 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Organic Chemistry, 34 papers in Molecular Biology and 15 papers in Pharmacology. Recurrent topics in M. K. Kathiravan's work include Synthesis and biological activity (34 papers), Computational Drug Discovery Methods (13 papers) and Synthesis and Characterization of Heterocyclic Compounds (12 papers). M. K. Kathiravan is often cited by papers focused on Synthesis and biological activity (34 papers), Computational Drug Discovery Methods (13 papers) and Synthesis and Characterization of Heterocyclic Compounds (12 papers). M. K. Kathiravan collaborates with scholars based in India, Saudi Arabia and South Korea. M. K. Kathiravan's co-authors include Aparna S. Chothe, Prashik B. Dudhe, Kishor S. Jain, Jesu Arockiaraj, Bharath Kumar Chagaleti, Rahul S. Kalhapure, Thirumala Govender, Jitender Bariwal, Anamik Shah and Bader O. Almutairi and has published in prestigious journals such as The Science of The Total Environment, Biochemical and Biophysical Research Communications and British Journal of Pharmacology.

In The Last Decade

M. K. Kathiravan

89 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The biology and chemistry of antifungal agents: A review

2012 531 citations M. K. Kathiravan et al. profile →

Peers

Countries citing papers authored by M. K. Kathiravan

Since Specialization

Citations

This map shows the geographic impact of M. K. Kathiravan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. K. Kathiravan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. K. Kathiravan more than expected).

Fields of papers citing papers by M. K. Kathiravan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. K. Kathiravan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. K. Kathiravan. The network helps show where M. K. Kathiravan may publish in the future.

Co-authorship network of co-authors of M. K. Kathiravan

This figure shows the co-authorship network connecting the top 25 collaborators of M. K. Kathiravan. A scholar is included among the top collaborators of M. K. Kathiravan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. K. Kathiravan. M. K. Kathiravan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular dynamics simulation reveals structural insights into isozyme selectivity of carbonic anhydrase XII inhibitors in hypoxic tumor microenvironment 2025 ·Biochemical and Biophysical Research Communications ·(unknown), (unknown), Bharath Kumar Chagaleti, (unknown), (unknown), M. K. Kathiravan	2
2	Renal protective efficiency of Isatin-linked Pyrazole (3E) derivative which mitigates gentamicin-induced nephrotoxicity and its anti-fibrotic mechanisms in an in-vivo zebrafish model 2025 ·Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology ·(unknown), (unknown), (unknown), (unknown), Girija Sastry Vedula, Ilavenil Soundharrajan, Bader O. Almutairi, M. K. Kathiravan, S. Karthick Raja Namasivayam, Jesu Arockiaraj	1
3	Discovery of selective mPGES-1 inhibitors through pharmacophore modeling, molecular docking, and quantum chemical analysis 2025 ·Biochemical and Biophysical Research Communications ·(unknown), M. Raja, M. K. Kathiravan	0
4	Computational drug discovery of nitroimidazole compounds targeting Ddn protein of Mycobacterium tuberculosis: insights from QSAR modeling, ADMET, molecular docking, and molecular dynamics simulation studies 2025 ·Medicine in Novel Technology and Devices ·(unknown), (unknown), (unknown), M. K. Kathiravan, (unknown)	1
5	A novel brominated chalcone derivative as a promising multi-target inhibitor against multidrug-resistant Listeria monocytogenes 2024 ·Microbial Pathogenesis ·B. Haridevamuthu, S.P. Ramya Ranjan Nayak, (unknown), (unknown), Bharath Kumar Chagaleti, Mukesh Pasupuleti, Rajakrishnan Rajagopal, Ahmed Alfarhan, M. K. Kathiravan, (unknown)	12
6	Protective role of 2-aminothiazole derivative against ethanol-induced teratogenic effects in-vivo zebrafish 2024 ·Biochemical Pharmacology ·(unknown), Gokul Sudhakaran, (unknown), A. C. SAU, M. K. Kathiravan, Mikhlid H. Almutairi, Bader O. Almutairi, (unknown), Jesu Arockiaraj	5
7	Exploring the cyclization of thiosemicarbazone to 1,3,4-thiadiazole: Synthesis, characterization and in-silico study 2024 ·Journal of Molecular Structure ·Yousef E. Mukhrish, Jehan Y. Al‐Humaidi, Bharath Kumar Chagaleti, Lamia A. Albedair, Sobhi M. Gomha, (unknown), M. K. Kathiravan, Ali Oubella	16
8	1,5- diaryl pyrazole-loaded chitosan nanoparticles as COX-2 inhibitors, mitigate neoplastic growth by regulating NF-κB pathway in-vivo zebrafish model 2024 ·International Journal of Biological Macromolecules ·Raghul Murugan, (unknown), B. Haridevamuthu, Ashok Kumar, Bharath Kumar Chagaleti, (unknown), Rajakrishnan Rajagopal, Ahmed Alfarhan, M. K. Kathiravan, Jesu Arockiaraj	5
9	Furan-based Chalcone Annihilates the Multi-Drug-Resistant Pseudomonas aeruginosa and Protects Zebra Fish Against its Infection 2024 ·The Journal of Microbiology ·S.P. Ramya Ranjan Nayak, (unknown), Seenivasan Boopathi, (unknown), Khaloud Mohammed Alarjani, (unknown), (unknown), M. K. Kathiravan, Jesu Arockiaraj	12
10	Combined effects of vitamin D3 and dioxopiperidinamide derivative on lipid homeostasis, inflammatory pathways, and redox imbalance in non‐alcoholic fatty liver disease in vivo zebrafish model 2024 ·Biotechnology and Applied Biochemistry ·(unknown), (unknown), (unknown), Manikandan Krishnan, (unknown), Rajakrishnan Rajagopal, Ahmed Alfarhan, S. Karthick Raja Namasivayam, M. K. Kathiravan, Jesu Arockiaraj	15
11	Neuroprotective potential of pyrazole benzenesulfonamide derivative T1 in targeted intervention against PTZ-induced epilepsy-like condition in in vivo zebrafish model 2024 ·International Immunopharmacology ·Raghul Murugan, S.P. Ramya Ranjan Nayak, B. Haridevamuthu, (unknown), (unknown), Bader O. Almutairi, Selvaraj Arokiyaraj, (unknown), M. K. Kathiravan, Jesu Arockiaraj	12
12	Co-occurrence of azorubine and bisphenol A in beverages increases the risk of developmental toxicity: A study in zebrafish model 2024 ·Food and Chemical Toxicology ·B. Haridevamuthu, S.P. Ramya Ranjan Nayak, Raghul Murugan, Gokul Sudhakaran, Raman Pachaiappan, Manikandan Krishnan, (unknown), Mikhlid H. Almutairi, Bader O. Almutairi, M. K. Kathiravan, Jesu Arockiaraj	4
13	Toxicity and therapeutic property of dioxopiperidin derivative SKT40 demonstrated in-vivo zebrafish model due to inflammatory bowel disease 2024 ·Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology ·(unknown), S.P. Ramya Ranjan Nayak, (unknown), (unknown), (unknown), Rajakrishnan Rajagopal, Ahmed Alfarhan, M. K. Kathiravan, Jesu Arockiaraj	5
14	Preliminary Phytochemical Analysis, <i>In-vitro</i> Evaluation of Antibacterial and Anticancer Activity of <i>Cleome aspera</i> Aerial Part Extracts 2024 ·Journal of Natural Remedies ·(unknown), M. K. Kathiravan, K. Ilango	0
15	Cadmium and ketoprofen accumulation influences aquatic ecosystem demonstrated using in-vivo zebrafish model 2024 ·Drug and Chemical Toxicology ·(unknown), Gokul Sudhakaran, (unknown), M. K. Kathiravan, Mikhlid H. Almutairi, Bader O. Almutairi, Selvaraj Arokiyaraj, Ajay Guru, Jesu Arockiaraj	13
16	Daidzein ameliorates nonmotor symptoms of manganese‐induced Parkinsonism in zebrafish model: Behavioural and biochemical approach 2024 ·British Journal of Pharmacology ·(unknown), Gokul Sudhakaran, Raman Pachaiappan, M. K. Kathiravan, Manikandan Krishnan, Mikhlid H. Almutairi, Bader O. Almutairi, Selvaraj Arokiyaraj, Jesu Arockiaraj	5
17	Design synthesis and biological evaluation of thiophene 2- pentafluoro benzamide derivatives as antitubercular agent 2023 ·Journal of medical pharmaceutical and allied sciences ·M. K. Kathiravan	2
18	Discovery and development of COVID‐19 vaccine from laboratory to clinic 2023 ·Chemical Biology & Drug Design ·(unknown), Bharath Kumar Chagaleti, (unknown), (unknown), (unknown), (unknown), Ramalingam Peraman, (unknown), M. Kavisri, Jesu Arockiaraj, M. K. Kathiravan, Meivelu Moovendhan‬‬‬‬‬‬‬‬	9
19	The Synergy of Combined Use of DMSO and Bronsted Acid (Ionic Liquid) as a Catalyst Part I: Efficient Niementowski Synthesis of Modified Quinazolinones 2011 ·Green and Sustainable Chemistry ·M. K. Kathiravan, (unknown), Trupti S. Chitre, (unknown), Kumar V. Srinivasan	8
20	An Efficient and Rapid Synthesis of 2-amino-4-arylthiazoles Employing Microwave Irradiation in Water 2011 ·Green and Sustainable Chemistry ·Kishor S. Jain, Jitender Bariwal, M. K. Kathiravan, (unknown), (unknown), (unknown), Satish N. Dighe	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact